09/22/2022 | Press release | Distributed by Public on 09/22/2022 14:13
Description of Action Reported
Upon Portage Biotech Inc. by action of its board of directors, amended its Memorandum of Association and Articles of Association (the "M&A") and on September 20, 2022, filed an updated version thereof with the Registrar of Companies in the British Virgin Islands. The principle purpose of the changes was to permit the company to hold virtual shareholder meetings. A copy of the revised M&A is filed herewith as an exhibit, and shareholders and investors are advised to carefully read the current version.
Exhibits
The following Exhibit is filed with this report:
Exhibit | Description | |
4.1 | Form of updated Articles of Association as of September 20, 2022 |